AU Stock MarketDetailed Quotes
NTI Neurotech International Ltd
- 0.069
- +0.003+4.55%
20min DelayNot Open Nov 26 16:00 AET
71.39MMarket Cap-11500P/E (Static)
0.074High0.068Low4.48MVolume0.070Open0.066Pre Close320.30KTurnover0.12552wk High0.59%Turnover Ratio1.03BShares0.04852wk Low-0.006EPS TTM52.85MFloat Cap0.486Historical HighLossP/E (Static)765.93MShs Float0.003Historical Low-0.006EPS LYR9.09%Amplitude--Dividend TTM5.75P/B1Lot Size--Div YieldTTM
About Neurotech International Ltd Company
Neurotech International Ltd is a medical device and solutions company conducting clinical studies to assess the neuroprotective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. Geographically, all the firm's business activities function through the region of Australia. It operates in one segment: Medical Device Development and Distribution.
Company Profile
SymbolNTI
Company NameNeurotech International Ltd
Founded2016
MarketASX
Fiscal Year Ends06-30
Address145 Stirling Highway Suite 5 CPC
CityNedlands
CountryAustralia
Zip Code6009
Phone+61 893893130
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Mark Davies
- Non-Executive Director,Non-Executive Chairman
- --
- Thomas (Tom) Duthy
- Executive Director
- --
- Robert (Max) Maxwell Johnston
- Non-Executive Director
- --
- Gerald Quigley
- Non-Executive Director,Director of Public Relations
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data